摘要
目的:探讨参附注射液治治疗慢性阻塞性肺病急性加重期的临床疗效。方法:70例患者随机分为两组,对照组患者给予氧疗、抗炎、平喘、解痉、止咳化痰等常规治疗,治疗组在对照组治疗的基础上给予参附注射液治疗,比较2组治疗后的临床疗效。结果:治疗组总有效率与对照组相比差异有显著性,P<0.05。结论:在慢性阻塞性肺病急性加重期常规治疗配合参附注射液治疗效果优于单纯常规治疗。
Objective To explore the clinical efficacy of Shenfu Injection in the treatment of acute exacerbation chronic obstructive pulmonary disease（AECOPD）.Methods 70 patients with（AECOPD） were randomly divided into treatment group of 35cases and control group of 35 cases.The control group was given conventional therapy,such as oxygen therapy,anti-inflammatory,preventing asthma,Spasmolysis,relieving cough,and so on.and the treatment group based on the control group was added with the Shenfu Injection.The clinical effective rate of the two groups were observed.Results The total effective rates of treatment group was significant higher than the control group,P0.05.Conclusion Conventional therapy combined with Shenfu Injection was significantly better than the group of conventional therapy with the clinic treatment effectiveness.
出处
《内蒙古中医药》
2013年第7期58-59,共2页
Inner Mongolia Journal of Traditional Chinese Medicine
关键词
慢性阻塞性肺病
急性加重期
参附注射液
疗效
acute exacerbation chronic obstructive pulmonary disease
Shenfu Injection
Efficacy
